Quadrature Capital’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,384
Closed -$362K 1516
2024
Q1
$362K Sell
12,384
-1,472
-11% -$46.9K 0.01% 854
2023
Q4
$504K Buy
+13,856
New +$454K 0.01% 669
2020
Q1
Sell
-7,183
Closed -$298K 693
2019
Q4
$298K Sell
7,183
-2,858
-28% -$120K 0.01% 402
2019
Q3
$459K Buy
10,041
+168
+2% +$7.32K 0.02% 404
2019
Q2
$426K Buy
+9,873
New +$417K 0.03% 326

Other funds holding SRDX

Quadrature Capital's SRDX Position: Q2 2024 in Review

Quadrature Capital sold out of Surmodics (SRDX) in Q2 2024, closing a stake of 12,384 shares — an estimated $362K sold.

Quadrature Capital first reported a position in SRDX in Q2 2019 and held it in 5 quarters. The position peaked at $504K in Q4 2023. 124 funds tracked by Wall St. Rank hold SRDX as of Q2 2024.

  • Quadrature Capital reported no remaining Surmodics position as of Q2 2024 after selling out during the quarter.
  • Quadrature Capital sold 12,384 Surmodics shares in Q2 2024, an estimated $362K.
  • Quadrature Capital first reported a position in Surmodics in Q2 2019 and held it in 5 quarters.
  • Quadrature Capital's Surmodics position peaked at $504K in Q4 2023.
  • 124 funds tracked by Wall St. Rank held Surmodics as of Q2 2024.

Based on Quadrature Capital's 13F filing for Q2 2024, filed 14 Aug 2024.